2 months This Promising Weight Loss Drug Candidate Could Be a Huge Growth Catalyst for Pfizer The Motley Fool
With danuglipron, Pfizer could become a major player in the massive GLP-1 agonist market.
With danuglipron, Pfizer could become a major player in the massive GLP-1 agonist market.